Difference between revisions of "Team:Bielefeld-CeBiTec"

Line 11: Line 11:
 
<div class="col-md-6 spacer_bottom_10px">
 
<div class="col-md-6 spacer_bottom_10px">
 
<div class="container text_header"><h2 style="border-bottom="2px #666633">Evobodies - Molecular Speed Dating</h2> </div>
 
<div class="container text_header"><h2 style="border-bottom="2px #666633">Evobodies - Molecular Speed Dating</h2> </div>
<div class="container text">We developed a novel and easy to use system for the generation of binding proteins in E. coli via in vivo directed evolution. Resulting proteins have the potential to be utilized for therapeutic or diagnostic purposes such as target-mediated drug delivery, immunodetection, or passive immunization. The system is particular useful for quick on-site generation of binders of evolving pathogens such as viruses. Moreover, many applications for basic research are within reach with limited hands on time and at low cost.
+
<div class="container text">We developed a novel and easy to use system for the generation of binding proteins in <i>E. coli</i> via <i>in vivo</i> directed evolution. Resulting proteins called Evobodies have the potential to bind specific to target proteins enabling varies medical and analytical applications. Big advantages of our low-cost system are the short hands on time and the short generation time.
As the starting point of our system, we designed and synthesized a library of sequences encoding binding proteins in E. coli based on Nanobodies as well as Monobodies. These libraries were cloned and are suggested as a new entity of BioBricks. The diversity of the library in E. coli is continuously increased by co-expressing a special DNA-Polymerase inducing plasmid restricted error-prone replication of the binding protein expressing plasmids. Finally, binding proteins with high affinity to the target protein are selected using a bacterial two-hybrid system conferring growth advantage to antibiotics in relation to protein-protein interaction. Ultimately, desired clones are enriched during fermentation either on plates or in continuous culture.  
+
<br>
Next to cloning the libraries, the selection and the evolution system, we validated the mutation system, defined the selection efficacy of our system and selected binding molecules.
+
<br>
 +
As the starting point of our system, we designed and synthesized a library of a new entity of BioBricks encoding binding proteins in <i>E. coli</i> based on Nanobodies as well as Monobodies. The diversity of the library in <i>E. coli</i> is continuously increased by co-expressing a special DNA-Polymerase conferring plasmid restricted error-prone replication of the binding protein expressing plasmids. Finally, binding proteins with high affinity to the target protein are selected using a bacterial two-hybrid system providing growth advantage to antibiotics in relation to protein-protein interaction strength. Ultimately, desired clones are enriched during fermentation in batch or in continuous culture.
 +
<br>
 +
<br>
 +
Binding capacities of our libraries, efficiency of our selection system and potential of our mutagenesis system were demonstrated. Moreover, library diversity and mutation system characteristics were analyzed in detail by high-throughput sequencing.
 
</div>
 
</div>
  

Revision as of 23:27, 19 October 2016



Evobodies - Molecular Speed Dating

We developed a novel and easy to use system for the generation of binding proteins in E. coli via in vivo directed evolution. Resulting proteins called Evobodies have the potential to bind specific to target proteins enabling varies medical and analytical applications. Big advantages of our low-cost system are the short hands on time and the short generation time.

As the starting point of our system, we designed and synthesized a library of a new entity of BioBricks encoding binding proteins in E. coli based on Nanobodies as well as Monobodies. The diversity of the library in E. coli is continuously increased by co-expressing a special DNA-Polymerase conferring plasmid restricted error-prone replication of the binding protein expressing plasmids. Finally, binding proteins with high affinity to the target protein are selected using a bacterial two-hybrid system providing growth advantage to antibiotics in relation to protein-protein interaction strength. Ultimately, desired clones are enriched during fermentation in batch or in continuous culture.

Binding capacities of our libraries, efficiency of our selection system and potential of our mutagenesis system were demonstrated. Moreover, library diversity and mutation system characteristics were analyzed in detail by high-throughput sequencing.

Achievements

Establishment of in vivo mutagenesis systems for the iGEM community
Design and construction of a library
Establishment of a functional selection system
Predict how our system work
Several human practice projects